Ovarian Cancer Diagnostic Promotes Rapid Detection and Treatment of Cancer

3 July 2020: Ovarian cancer is the tenth most common cause of cancer among women in the United States and the fifth most common cause of cancer deaths in women across the globe. The incidences of ovarian cancer are high in women aged 55-64 years and the major symptoms are abdominal and pelvic pain, urinary symptoms, bloating, and difficulty in eating. Staging process helps identify ovarian tumors, calculate their size, and detect metastasis and invasion and in order to improve patient survival rates early detection and diagnosis are of utmost significance. 

Advanced Imaging Techniques Fuel Segment Growth

Based on cancer type, the ovarian cancer diagnostic market can be segmented into epithelial tumor, germ cell tumor, stromal cell tumor, and others. Based on the location where cancerous cells have developed, the type of ovarian cancer is determined. In 2018, in this segment epithelial tumors remained a forerunner, accounting for over 90% of all ovarian malignancies. Epithelial tumors can be mucinous, serous, endometrioid, or clear cell. Treatment options and survival rates are majorly reduced due to diagnosis of almost seventy to eighty percent of patients in the advanced stage.  

Stromal cell and germ cell tumors collectively own a small share of the ovarian cancer diagnostic market. Stromal tumors develop in the tissues responsible for producing hormones such as testosterone, estrogen, and progesterone while in women aged between 20 to 30 years, germ cell tumors are most prevalent. 

In 2018, imaging techniques accounted for the largest share of the market due to its extensive usage in cancer staging and increasing importance of early diagnosis of the disease. In order to measure the size and view a tumor internally, transvaginal ultrasound remains the preliminary imaging technique while a CT scan is preferred for cancer staging and is limited to small tumors. In order to detect metastasis and disease severity, more advanced imaging techniques such as PET and MRI scans are used. The market for blood tests is expected to witness a steady growth on account of increasing consumer awareness and technological advancements.

Market Insights

Growth of the market can be attributed to rising prevalence of ovarian cancer and emergence of novel diagnostic products. There is an increasing need to develop novel therapies and new medicines for early and timely diagnosis of this cancer and its treatment. Thus, the global market for diagnostics and therapeutics shows immense potential for growth and development. Rise in funding for ovarian cancer research and increase in number of initiatives by governments are major factors responsible for driving the market growth. 

Some of the major companies of the ovarian cancer diagnostic market are GlaxoSmithKline plc; F. Hoffmann-La Roche Ltd.; Johnson & Johnson Services, Inc.; Siemens Healthcare GmbH; AstraZeneca plc; Quest Diagnostics Incorporated.; Bio-Rad Technologies Inc.; Thermo Fisher Scientific; and Abbott.

Demand for Rapid Diagnostic Tests Boost Critical Care Diagnostics Growth

16 April 2020: Critical care diagnostics also termed as the point of care (POC) are the approved tests that offer quick result and are performed near the patient. Over the counter and self-testing also come under critical care diagnostics. Critical care diagnostics comprise of cardiac markers diagnostics, cancer biomarker test, blood glucose testing, blood gas and electrolyte analysis, pregnancy testing, drugs of abuse, food pathogens screening, urine stripe testing, cholesterol screening, infectious disease testing, and hemoglobin diagnostics.

Immunoproteins Segment Contribute Dominant Share in the End User Segment 

The major application variants of the critical care diagnostics market include flow cytometry, routine and special chemistry, hematology, microbial and infectious diseases, coagulation, immunoproteins, and others. 

The immunoproteins sector accounted for the largest share in the market and is anticipated to expand at the fastest CAGR in the forthcoming period. The factors that attributed to the growth include an increase in the demand for accurate and rapid diagnosis and the ability to decrease the recovery time of patients.

In addition, increasing availability, growing patient population base, and consciousness about infectious disease POC testing products are the key factors contributing to the sector’s development in the forecast period. As the consciousness levels of patients for improved healthcare selections have enhanced and physician’s data of target therapy has improved, the demand for these diagnostics has extended. 

The growth of the global market is mainly driven by factors, such as flow cytometry tests, coagulation tests, and clinical chemistry among others. Furthermore, microbiology and infectious tests with immunoproteins assays are anticipated to propel segment growth in the years to come.

Market Insights: 

The key players are majorly involved in new product development, technological advancements, joint ventures, collaborations, and partnerships, to uphold their position in the industry.  For instance, in February 2016, Abbott acquired healthcare management company i.e. Alere, which is offering the point-of-care solution. 

For instance, the i-Stat blood gas analyzer by Abbott associated self-contained cartridges with microfluidic constituents and electrochemical detection, providing sensitive, and accurate results. Demand for cost-efficient, accurate, and rapid diagnostic tests, and increasing awareness are expected to initiate developments in the market. Leading players operating in the critical care diagnostics market are Alere, Inc.; Abbott.; Beckman-Coulter; Becton Dickinson & Co.; and Roche Diagnostics among others.

Capillary Blood Collection Devices to Perform Various Diagnostic Tests

Tuesday, 4 February 2018: Capillary blood collection devices can be referred to medical devices that are used to draw blood from human body to perform various diagnostic tests. These devices can be light-weight, easy to handle, and offer protection from contamination. Blood collection is expected to play important role in diagnostic procedures, which are performed at diagnostic centers and hospitals. Efficient diagnosis can help doctors know accurate medical condition of their patients. Hence, doctors can proceed with correct treatment and medication of patients in time. 

New Lancet Based HIV Test to Deliver Accuracy

Major product variants of capillary blood collection devices are lancets, mic

ro-container tubes, micro hematocrit tubes, warming devices, and others. Lancets are expected to maintain their dominance during the forecast period attributed to increasing use in blood draw procedures. They are likely to offer small scalpel to puncture skin in order to collect blood sample. Rising cases of chronic diseases and infections can impel product demand in coming years. Reusable and disposable can be considered as two variants of lancets. Disposable lancets are expected to be used in hospital settings and clinics, where huge number of patients are tested for chronic diseases and infections. Reusable lancets are likely to be used in homecare settings for routine hemoglobin and glucose analysis in anemic and diabetic patients. Launch of advanced products by manufacturing companies to perform diagnostic tests can gain traction among consumers. For instance, Owen Mumford recently launched a diagnostic test of HIV that can provide accurate results within 15 minutes. This test called Simplitude Pro HIV, is expected to include built-in safety lancet (blood collection unit) and strip test to use blood as directly as possible. In addition, the device is expected to draw sufficient amount of blood to deliver accuracy.       

Market Insights

The global capillary blood collection devices market is anticipated to reach USD 1.75 billion by 2025, according to a report by Grand View Research, Inc. Rising demand for POC diagnostics attributed to increasing cases of chronic cases across the globe. Increasing number of no communicable and infectious diseases is anticipated to give rise to chronic diseases. Antimicrobial resistance, poverty in developing countries, and rapid urbanization cab be considered as major factors that can lead to prevalence of various chronic diseases. Advent of advanced technologies in healthcare sector such as biosensors, bioanalytical platforms, novel assay formats, and other complementary research techniques can augment market growth. Availability of novel molecular technology can provide fast diagnosis at convenience and reduced costs. This, in turn, can influence growth of market in coming years. Increasing use of capillary blood collection devices in owing to its advantages like low cost, less invasive, and no requirement of professional for blood draw procedure can stimulate market growth.          

Some of the leading companies operating in the market for capillary blood collection devices are Becton, Dickinson and Company, Terumo Medical Corporation, Cardinal Health, Owen Mumford Ltd., and Greiner Bio One International GmbH.

Isothermal Nucleic Acid Amplification Technology to Boost Healthcare

21 September 2018: Growing prevalence of chronic and infectious diseases is anticipated to stimulate demand for Isothermal Nucleic Acid Amplification Technology (INAAT). The INAAT technologies can expedite diagnostic procedures for various health disorders. Major technology variants of INAAT are nucleic acid sequence based amplification (NASBA), helicase-dependent amplification (HDA), transcription-mediated amplification (TMA), loop-mediated isothermal amplification (LAMP).

TMA to be the Leading Technology Segment

TMA is likely to be the dominating segment during the forecast period (from 2018 to 2025), being the first INAAT introduced for consumers. Increasing cases of chronic disorders, such as cancer and other infectious diseases, are predicted to impel demand for such medical technologies. Considering the rising demand, most manufacturing companies are focusing on R&D and technological advancements to offer advanced products.

For instance, Hologic recently announced its third Panther Fusion assay that got clearance from the FDA. This new assay can detect rhinovirus, adenovirus, and human metapneumovirus. Other two assays under Panther Fusion System are Panther Fusion Paraflu assay and Panther Fusion Flu A/B/RSV assay. All these assays deliver modular approach to syndromic respiratory tests.

Market Insights

The worldwide Isothermal Nucleic Acid Amplification Technology (INAAT) market is predicted to reach USD 4.3 billion by 2025, according to a report by Grand View Research, Inc. Growing geriatric population base is likely to drive the global market. Growing necessity for rapid, disease-specific, and user-friendly kits to stimulate diagnosis of various infections can exhilarate market growth. Rising adoption of molecular diagnostics owing to increase in disposable income can also augment the growth of this market.

Increasing cases of chronic infections, such as respiratory viral infections, diarrhea, and pneumonia, would also fuel market growth. Moreover, miniaturization of nucleic acid-based diagnostic procedures can impel demand for INAAT. Some of the prominent companies in the market are QIAGEN, Becton, Dickinson and Company, Quidel Corporation, and Thermo Fisher Scientific.

Read more @ 

https://www.grandviewresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-inaat-market

ECG Equipment and Management System to Prevent Heart Attacks

Growing requirement for timely detection of any abnormalities in functionality of heart is anticipated to propel demand for ECG equipment and management systems. Such systems monitor various parameters related to heart that can support better diagnosis of possible heart disorders. Increasing cases of untimely heart attacks in youngsters and adults are anticipated to further fuel the product demand in the coming years.

New Smart Watches to Detect Abnormalities in Heart

Major product-variants of ECG equipment and management system are resting ECG system, stress ECG monitors, holter monitors, event monitoring systems, and ECG management system. Resting ECG systems led the product segment in 2016. However, the ECG management system segment is likely to account for the maximum growth over the forecast years (from 2017 to 20025) owing to their ease of use, advent of innovative products, and better efficiency. Due to this, most ECG equipment and management system manufacturing companies are focusing on R&D activities to develop advanced products for better diagnostic results.

For instance, recently, Apple Inc. had designed an advanced heart monitoring system for its smart watches. The company has added highly sensitive sensors in these smart watches to predict possible infirmities while relying on previously recorded data or historical events. In 2017, Bittium had launched an innovative software solution that analyzes cardiac events based on long-term Holter measurements and ECG measurements. This helps detect cardiac arrhythmias and in-depth analysis of long –term recordings.

Market Overview

The global ECG equipment and management system market is expected to reach USD 7.63 billion by 2025, according to a report by Grand View Research, Inc. Increasing cases of heart-related disorders such as ischemic heart disease, heart arrhythmia, and heart attack as a result of rising geriatric population base can impel the growth of this market.

Continuous technological development in the healthcare sector for early detection of cardiovascular diseases can further stimulate the market demand. Moreover, supportive government regulations towards health awareness and infrastructural development is also anticipated to drive market development over the coming years. Some of the leading companies offering ECG equipment and management system are Mindray Medical; Compumed Inc.; GE Healthcare; BioTelemetry, Inc.; and Hill Rom.

In-Depth research report on ECG equipment and management system market:

https://www.grandviewresearch.com/industry-analysis/ecg-management-systems-market

ECG Equipment and Management System to Prevent Heart Attacks

Growing requirement for timely detection of any abnormalities in functionality of heart is anticipated to propel demand for ECG equipment and management systems. Such systems monitor various parameters related to heart that can support better diagnosis of possible heart disorders. Increasing cases of untimely heart attacks in youngsters and adults are anticipated to further fuel the product demand in the coming years.

New Smart Watches to Detect Abnormalities in Heart

Major product-variants of ECG equipment and management system are resting ECG system, stress ECG monitors, holter monitors, event monitoring systems, and ECG management system. Resting ECG systems led the product segment in 2016. However, the ECG management system segment is likely to account for the maximum growth over the forecast years (from 2017 to 20025) owing to their ease of use, advent of innovative products, and better efficiency. Due to this, most ECG equipment and management system manufacturing companies are focusing on R&D activities to develop advanced products for better diagnostic results.

For instance, recently, Apple Inc. had designed an advanced heart monitoring system for its smart watches. The company has added highly sensitive sensors in these smart watches to predict possible infirmities while relying on previously recorded data or historical events. In 2017, Bittium had launched an innovative software solution that analyzes cardiac events based on long-term Holter measurements and ECG measurements. This helps detect cardiac arrhythmias and in-depth analysis of long –term recordings.

Market Overview

The global ECG equipment and management system market is expected to reach USD 7.63 billion by 2025, according to a report by Grand View Research, Inc. Increasing cases of heart-related disorders such as ischemic heart disease, heart arrhythmia, and heart attack as a result of rising geriatric population base can impel the growth of this market.

Continuous technological development in the healthcare sector for early detection of cardiovascular diseases can further stimulate the market demand. Moreover, supportive government regulations towards health awareness and infrastructural development is also anticipated to drive market development over the coming years. Some of the leading companies offering ECG equipment and management system are Mindray Medical; Compumed Inc.; GE Healthcare; BioTelemetry, Inc.; and Hill Rom.

Read more at:

https://www.grandviewresearch.com/industry-analysis/ecg-management-systems-market

Structural Heart Imaging to Provide Relief to SHD Patients

Structural heart disease (SHD) is a congenital defect normally seen in children or adults. More than 70,000 children in the European Union (EU) and the U.S. are reportedly afflicted with SHD annually. The three common defects associated with SHD are patent foramen of ovale (PFO), coarctation of the aorta, and atrial septal defect (ASD). Developments in MRI have led to dosage reduction of radiation making it a preferable option for diagnosing children and pregnant women. 

Echocardiogram to Emerge as the Biggest Segment by 2025

Structural heart imaging (SHI) consists of imaging technologies used to identify structural heart diseases. These technologies include echocardiogram, magnetic resonance imaging (MRI), and computed tomography (CT). The echocardiogram segment is anticipated to be the biggest segment by 2025 due to its capacity to generate high-quality images of internal vessels of the heart. The segment is witnessing impressive innovations in terms of technology. For instance, Siemens Healthineers has introduced the Acuson SC2000 Prime Edition that utilizes transesophageal echocardiography (TEE). This machine can assist surgeons or diagnosticians in offering accurate solutions to SHD-prone patients.

The MRI segment, on the other hand, is expected to grow at a rapid rate till 2025 due to technological improvements in MRI devices. The Signa Premier by GE Healthcare is a prime example of advanced MRI technology. It is expected to be used in diagnosing more complex forms of congenital heart diseases after gaining approval from the U.S. Food and Drug Administration (FDA).

Market Overview

According to Grand View Research, Inc.; the global structural heart imaging (SHI) market is expected to reach a market size above USD 25 billion by 2025. Rising incidence of structural heart disease among children and adults is the primary market driver. Advancements in imaging technologies are anticipated to spur market growth. Introduction of minimally advanced technologies such as transcatheter mitral valve repair (TMVR) and transcatheter aortic valve repair (TAVR) are projected to open up new avenues for market growth.

High cost of interventional surgical procedures may act as a market deterrent in near future. Key market players include Siemens Healthineers; Shimadzu Corporation; HeartSciences; and TomTec Imaging Systems GmbH. The future of the market largely depends on the adoption of 3D imaging technologies. Technologies like 3D transesophageal echocardiography (TOE) and mult-slice computed tomography (MSCT) can play a vital role in increasing the success rate of operations.

Access full research report at: 

www.grandviewresearch.com/industry-analysis/structural-heart-imaging-shi-market

Vitamin D Testing for Preventing Chronic Illness

Vitamin D is a fat-soluble vitamin, principally obtained from sun exposure. It is available naturally in some food and it can be consumed in the form of dietary supplements.

Vitamin D comes in two forms, namely, ergocalciferol (vitamin D2), which is present in some fish and plants and cholecalciferol (vitamin D3), which is obtained from the sun. It is the predominant source of vitamin D for humans. 

Significance of Vitamin D

This vitamin helps intestinal absorption of calcium, phosphate, zinc, magnesium, and many other nutrients. It is essential for overall health improvement and especially for the growth of strong and healthy bones. Vitamin D as also reduces inflammation and improves the neuromuscular and immune function.

Deficiency of vitamin D makes the bones thin and fragile. It can also case rickets in kids and osteomalacia in adults. Children below the age five, pregnant and breast-feeding women, people with very little exposure to sunlight, and persons with darker skin tones can be at a higher risk of vitamin D deficiency.

Advanced Flash Chemiluminescence (CLIA) Technology

Two types of tests are used to inspect the level of Vitamin D in the body, namely, 25-Hydroxy Vitamin D abbreviated as 25 (OH) D and 1, 25-Dihydroxy Vitamin D. 

DiaSorin, an Italian multinational biotechnology company has developed ‘‘LIAISON’’ analyzer. The system uses chemiluminescent immunoassay (CLIA) technology to perform quantifiable determination of 25 (OH) D in human serum. The result of the test must be used in the combination with other clinical or laboratory examination.

The company’s another product; ‘LIAISON XL’ is a fully automated chemiluminescence analyser. It functions based on a “Flash” chemiluminescence (CLIA) technology with paramagnetic microparticle solid phase. It can perform complete sample processing along with measurement and evaluation of vitamin D levels.

Market Overview

According to Grand View Research, Inc.; the global vitamin D testing market is set to achieve nearly USD 1.1 billion by 2025. Increasing geriatric population and prevalence of celiac disease is projected to drive the market during the forecast period (2014 to 2025).

The 25 (OH) D test sector is anticipated to continue dominating the overall market during the forecast period. In 2016, North America led the market due to the presence of developed health care infrastructure and high awareness regarding routine screening and availability of the advanced products. Asia Pacific may emerge as the fastest growing region in the near future owing to improved healthcare infrastructure and expenditure in India, China, and Japan.

To get free sample report at:

http://www.grandviewresearch.com/industry-analysis/vitamin-d-testing-market/request